AbbVie 2012 Annual Report Download - page 51
Download and view the complete annual report
Please find page 51 of the 2012 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41 -
42 -
43 -
44 -
45 -
46 -
47 -
48 -
49 -
50 -
51 -
52 -
53 -
54 -
55 -
56 -
57 -
58 -
59 -
60 -
61 -
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127
-
128
-
129
-
130
-
131
-
132
-
133
-
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
-
161
-
162
-
163
-
164
-
165
-
166
-
167
-
168
-
169
-
170
-
171
-
172
-
173
-
174
-
175
-
176
-
177
-
178
-
179
-
180
-
181
-
182
-
183
-
184
-
185
-
186
-
187
-
188
-
189
-
190
-
191
-
192
-
193
-
194
-
195
-
196
-
197
-
198
-
199
-
200
 |
 |
The increase in sales was primarily due to higher HUMIRA sales, partially offset by the impact of
unfavorable foreign currency and the entry of generic TriCor in the fourth quarter of 2012.
The following table details the sales of key products.
Percent change
At actual At constant
currency currency
rates rates
years ended December 31 (in millions) 2012 2011 2010 2012 2011 2012 2011
HUMIRA
United States $ 4,377 $ 3,427 $ 2,872 28% 19% 28% 19%
International 4,888 4,505 3,636 8% 24% 15% 17%
Total $ 9,265 $ 7,932 $ 6,508 17% 22% 21% 18%
AndroGel
United States $ 1,152 $ 874 $ 649 32% 35% 32% 35%
TriCor/TRILIPIX
United States $ 1,098 $ 1,372 $ 1,355 (20)% 1% (20)% 1%
Kaletra
United States $ 279 $ 326 $ 363 (14)% (10)% (14)% (10)%
International 734 844 860 (13)% (2)% (7)% (5)%
Total $ 1,013 $ 1,170 $ 1,223 (13)% (4)% (9)% (7)%
Niaspan
United States $ 911 $ 976 $ 927 (7)% 5% (7)% 5%
Synagis
United States $ 17 $ 17 $ 16 — 5% — 5%
International 825 775 710 6% 9% 9% 4%
Total $ 842 $ 792 $ 726 6% 9% 9% 5%
Lupron
United States $ 569 $ 540 $ 483 5% 12% 5% 12%
International 231 270 258 (14)% 4% (11)% (1)%
Total $ 800 $ 810 $ 741 (1)% 9% — 7%
Sevoflurane
United States $ 82 $ 88 $ 126 (7)% (30)% (7)% (30)%
International 520 577 538 (10)% 7% (5)% 3%
Total $ 602 $ 665 $ 664 (10)% — (5)% (3)%
Synthroid
United States $ 551 $ 522 $ 451 6% 16% 6% 16%
Norvir
United States $ 276 $ 289 $ 241 (4)% 20% (4)% 20%
International 113 130 103 (13)% 27% (8)% 22%
Total $ 389 $ 419 $ 344 (7)% 21% (5)% 19%
Zemplar
United States $ 230 $ 255 $ 476 (10)% (46)% (10)% (46)%
International 153 154 120 (1)% 28% 6% 25%
Total $ 383 $ 409 $ 596 (6)% (31)% (4)% (32)%
Creon
United States $ 353 $ 332 $ 246 6% 35% 6% 35%
Other $ 1,021 $ 1,171 $ 1,208 (13)% (3)% (11)% (4)%
Total $18,380 $17,444 $15,638 5% 12% 8% 9%
45